INAB · Forms 3, 4, 5
Insider trades at IN8BIO, INC.
No open-market insider buys or sells at IN8BIO, INC. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for IN8BIO, INC. (INAB) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for IN8BIO, INC. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Emily Fairbairn | Director | Gift | 724,637 | Form 4 | |||
| William Tai-Wei Ho | CEO | Options or other derivatives | Form 4 | ||||
| Luba Greenwood | Director | Options or other derivatives | Form 4 | ||||
| Lawrence Lamb | EVP and CSO | Options or other derivatives | Form 4 | ||||
| Emily Fairbairn | Director | Options or other derivatives | Form 4 | ||||
| Patrick McCall | CHIEF FINANCIAL OFFICER | Options or other derivatives | Form 4 | ||||
| Kate Rochlin | President and COO | Options or other derivatives | Form 4 | ||||
| Corinne Epperly | Director | Options or other derivatives | Form 4 | ||||
| Peter C. Brandt | Director | Options or other derivatives | Form 4 | ||||
| Jeremy R. Graff | Director | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.